Clinical analysis of efficacy results in 105 breast cancer patients treated with breast conserving surgery

doi:10.3877/cma.j.issn.1674-0807.2007.03.010

Abstract

Abstract:

Objective

To study the short-term therapeutic effect of breast conserving surgery for patients with early stage breast cancer.

Methods

The survival rate，recurrence and shape were retrospectively analyzed in 105 patients with breast cancer who received breast conserving surgery and adjuvant radiotherapy from January，2001 to December，2005.

Results

The 105 patients with breast cancer received breast conserving surgery，followed by radiotherapy.All the patients were followed up for a median period of 24 months（15-86 months）and the average of 37.4 months.Forty-seven cases were followed up over 3 years.The 3-year overall survival rate was 100%，and disease free survival rate was 95.7%，2 cases experienced local relapse.The ave-rage interval between operation and relapse was 21 months.Distant bone metastases were found in 2 cases.The median interval between operation and metastasis was 18 months.The cosmetic results of 85 patients were evaluated as good 47.1%，fair 50.6%，and poor 2.6%.

Conclusions

For early breast cancer patients，breast conserving surgery followed by radiotherapy can obtain excellent local control and good cosmetic results.

Key words: Breast neoplasms, Breast conserving surgery

Dong-min WANG, Jing-ming YE, Yin-hua LIU. Clinical analysis of efficacy results in 105 breast cancer patients treated with breast conserving surgery[J]. Chinese Journal of Breast Disease(Electronic Edition), 2007, 01(03): 33-35.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhrxbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0807.2007.03.010

https://zhrxbzz.cma-cmc.com.cn/EN/Y2007/V01/I03/33

Figures/Tables 1

References 9

［1］	Fisher B，Anderson S，Redmond C K，et al.Reanalysis and results after 12 years of follow up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer.N Engl J Med 1995，333：1456-1461.
［2］	Veronesi U，Salvadori B，Luini A，et al.Breast conservation is a safe method in patients with small cancer of the breast：long-term results of three randomized trials on 1973 patients.Eur J Cancer 1995，31：1574-1579.
［3］	张保宁.乳腺癌外科100年.中华肿瘤杂志，2003，25：618-621.
［4］	Morrow M，Strom E A，Bassett L W，et al.Standard for breast conservation therapy in the management of invasive breast carcinoma.CA Cancer J Clin，2002，52：277-300.
［5］	Fisher B，Anderson S，Bryant J，et al.Twenty-year follow-up of a randomized trial comparing total mastectomy，lumpectomy，and lumpectomy plus irradiation for the treatment of invasive breast cancer.N Engl J Med，2002，347：1233-1241.
［6］	Early Breast Cancer Trialists'Collaborative Group.Effects of radiotherapy and surgery in early breast cancer：an overview of the randomized trials.N Engl J Med，1995，333：1444-1455.
［7］	Winchester D J，Menck H R，Winchester D P.The National Cancer Data Base report on the results of a large nonrandomized comparison of breast preservation and modified radical mastectomy.Cancer，1997，80：162-167.
［8］	张保宁，余子豪.乳腺癌保乳手术的几个关键问题.中华肿瘤杂志，2001，23：523-524.
［9］	Rose M A，Olivotto I，Cady B，et al.Conservative surgery and radiation therapy for early breast cancer：long-term cosmetic results.Arch Surg，1989，124：153-157.

时间	病理类型				肿瘤大小			淋巴结转移			ER-/PR-/HER-2+	ER-/PR-/HER-2-	切缘
时间	浸润性导管癌	导管内癌	黏液癌	其他癌	T1	T2	T3	0枚	1～3枚	≧4枚	ER-/PR-/HER-2+	ER-/PR-/HER-2-	切缘
2001	6	1	1	1^a	5	3	1	6	3	0	0	1	阴性
2002	5	0	0	0	5	0	0	5	0	0	2	0	阴性
2003	8	0	0	0	8	0	0	6	1	1	2	0	阴性
2004	46	3	0	1^b	35	14	1	42	5	3	10	1	阴性
2005	24	7	1	1^c	19	14	0	26	6	1	4	3	阴性

时间	病理类型				肿瘤大小			淋巴结转移			ER-/PR-/HER-2+	ER-/PR-/HER-2-	切缘
时间	浸润性导管癌	导管内癌	黏液癌	其他癌	T1	T2	T3	0枚	1～3枚	≧4枚	ER-/PR-/HER-2+	ER-/PR-/HER-2-	切缘
2001	6	1	1	1^a	5	3	1	6	3	0	0	1	阴性
2002	5	0	0	0	5	0	0	5	0	0	2	0	阴性
2003	8	0	0	0	8	0	0	6	1	1	2	0	阴性
2004	46	3	0	1^b	35	14	1	42	5	3	10	1	阴性
2005	24	7	1	1^c	19	14	0	26	6	1	4	3	阴性

[1]	Yang Li, Jinyu Cai, Xiaozhi Dang, Wanying Chang, Yan Ju, Yi Gao, Hongping Song. Application value of a deep learning-based model for generating strain elastography images using breast grayscale ultrasound images [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(06): 563-570.
[2]	Collaboration Group，Breast Cancer Specialty Committee，Hebei Anti-Cancer Association Nursing. Expert consensus on nursing management of central venous access in breast cancer patients [J]. Chinese Journal of Breast Disease(Electronic Edition), 2024, 18(06): 321-329.
[3]	Chenlu Liu, Jie Liu, Fan Zhang, Caiying Yan, Qian Chen, Shuangqing Chen. Habitat analysis based on enhanced MRI radiomic features in predicting HER-2 expression in breast cancer [J]. Chinese Journal of Breast Disease(Electronic Edition), 2024, 18(06): 339-345.
[4]	Xiaoyu Zhang, Yulai Yin, Yinxu Zhang. Efficacy and prognostic analysis of apatinib combined with neoadjuvant chemotherapy in triple negative breast cancer [J]. Chinese Journal of Breast Disease(Electronic Edition), 2024, 18(06): 346-352.
[5]	Lin Qiu, Jinhui Liu, Tuerhong Zumureti, Yuexin Ma, Xiaoling Leng. Diagnostic value of ultrasound radiomics in non-mass breast cancer in dense breasts [J]. Chinese Journal of Breast Disease(Electronic Edition), 2024, 18(06): 353-360.
[6]	Rui Ge, Fei Chen, Jie Li, Juanjuan Li, Han Chen. Application of multi-gene panel testing in adjuvant therapy for early breast cancer [J]. Chinese Journal of Breast Disease(Electronic Edition), 2024, 18(05): 257-263.
[7]	Liu Yang, Zhenchuan Song, Xinle Wang. Clinical efficacy evaluation of modified radical mastectomy combined with latissimus dorsi muscle repositioning [J]. Chinese Journal of Breast Disease(Electronic Edition), 2024, 18(05): 269-273.
[8]	Rui Wang, Jun Deng, Tingxin Shi, Zhizhao Zhang, Chengfang Wang, Yi Zhang, Xiaowei Qi. FAM91A1 is a potential prognostic factor in breast cancer [J]. Chinese Journal of Breast Disease(Electronic Edition), 2024, 18(05): 274-280.
[9]	Sihan Ji, Xinyu Tang, Bangjie Wang, Wenyang Di, Jiaming Wang, Xiaoming Zha, Hui Xie, Wenbin Zhou, Hong Pan, Shui Wang. Safety of abemaciclib in hormone receptor-positive/HER-2 negative breast cancer patients [J]. Chinese Journal of Breast Disease(Electronic Edition), 2024, 18(05): 281-286.
[10]	Mengmeng Han, Xueyuan Feng, Ning Ma. A case of radial nerve injury after modified radical surgery for breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 117-118.
[11]	Jiehong Gao, Pingping Li, Jing Qi, Yinhai Dai. Study on the relationship between the expression of ETFA gene and clinicopathological parameters and prognosis in breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 64-67.
[12]	Zhizhao Zhang, Rui Wang, Pingping Gao, Chengfang Wang, Cheng Wang, Xiaowei Qi. Relationship between DNMT3B and prognosis of breast cancer and its biological mechanism [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 624-629.
[13]	Lingyan Wang, Chunhui Gao, Xueyuan Feng, Xinmiao Cui, Huan Liu, Wenming Zhao, Jinku Zhang. Application of circulating tumor cells in neoadjuvant and postoperative adjuvant therapy for breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 630-633.
[14]	Linjuan Zhao, Jie Lv, Wensheng Wang, Demao Ma, Tao Hou. Study on the effect of ultrasound guided resection of stellate and cylindrical lactation preserving areas with staining marks [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 634-637.
[15]	Chengxin Huang, Li Chen, Yichu Liu, Shuiliang Wang, Xiaofeng Lai. Expression characterization OPA1 expression in breast cancer tissues and its biological function in ER-positive breast cancer cells [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2024, 14(05): 275-284.

Please choose a citation manager

Content to export